Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals
about
Frequency-modulated pulses of ERK activity transmit quantitative proliferation signals.Impairment of the activin A autocrine loop by lopinavir reduces self-renewal of distinct human adipose progenitors.The associations between immunity-related genes and breast cancer prognosis in Korean women.Fibrillarin from Archaea to human.Down-regulation of cyclin G2 by insulin, IGF-I (insulin-like growth factor 1) and X10 (AspB10 insulin): role in mitogenesis.Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinib.The butterfly effect in cancer: a single base mutation can remodel the cell.Intercellular propagation of extracellular signal-regulated kinase activation revealed by in vivo imaging of mouse skin.The transcription factor EGR1 localizes to the nucleolus and is linked to suppression of ribosomal precursor synthesisThe serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase.Down-Regulation of miR-129-5p and the let-7 Family in Neuroendocrine Tumors and Metastases Leads to Up-Regulation of Their Targets Egr1, G3bp1, Hmga2 and Bach1.Transcriptome study and identification of potential marker genes related to the stable expression of recombinant proteins in CHO clones.EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF.Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage.Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo.The cell cycle regulator ecdysoneless cooperates with H-Ras to promote oncogenic transformation of human mammary epithelial cells.p27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability.Temporal mapping of CEBPA and CEBPB binding during liver regeneration reveals dynamic occupancy and specific regulatory codes for homeostatic and cell cycle gene batteriesSTAT3-mediated coincidence detection regulates noncanonical immediate early gene induction.Meet me in the cytoplasm: A role for p27(Kip1) in the control of H-Ras.Unraveling Growth Factor Signaling and Cell Cycle Progression in Individual FibroblastsEgr-1 is a critical regulator of EGF-receptor-mediated expansion of subventricular zone neural stem cells and progenitors during recovery from hypoxia-hypoglycemia.Dynamics of Protein Expression Reveals Primary Targets and Secondary Messengers of Estrogen Receptor Alpha Signaling in MCF-7 Breast Cancer CellsG0-G1 transition and the restriction point in pancreatic β-cells in vivo.Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancerConsistency test of the cell cycle: roles for p53 and EGR1.Start and the restriction point.Receptor Level Mechanisms Are Required for Epidermal Growth Factor (EGF)-stimulated Extracellular Signal-regulated Kinase (ERK) Activity PulsesMolecular Targeting of Growth Factor Receptor Signaling in Radiation Oncology.EGR1 is critical for gastrin-dependent upregulation of anion exchanger 2 in gastric cancer cells.p53 modulates acquired resistance to EGFR inhibitors and radiation.Intense THz pulses cause H2AX phosphorylation and activate DNA damage response in human skin tissue.Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma.A crossroad of microRNAs and immediate early genes (IEGs) encoding oncogenic transcription factors in breast cancer.RNF20 and histone H2B ubiquitylation exert opposing effects in Basal-Like versus luminal breast cancer.Functional antagonism of β-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes.Tracing Information Flow from Erk to Target Gene Induction Reveals Mechanisms of Dynamic and Combinatorial Control.A Precise Cdk Activity Threshold Determines Passage through the Restriction Point.An EZH2-mediated epigenetic mechanism behind p53-dependent tissue sensitivity to DNA damage.Mathematical modelling of reversible transition between quiescence and proliferation.
P2860
Q30586789-84CF96DC-A116-4587-B734-9B7FA02202EAQ33774103-7ABD02CB-7530-4366-AA8A-B1BAF86F92CDQ33975510-A0006806-51E0-45C6-9062-E14DB7024320Q34043464-EC215F6D-D020-45AE-B0BD-FEC2CB9AD110Q34372865-852B04D8-C1AB-458E-8E0A-D5D4FD58F6D2Q35012485-B162C71A-C8C9-4A71-87F8-89537BC45DA8Q35037970-D2DB6BF5-CBFA-48D5-9AA5-C1B7F87935D0Q35111321-D01CD135-5851-44DD-A1D3-AA3917875F9DQ35161251-F5F21417-AB51-4F39-9D29-CEE5663944DBQ35185357-8A07B882-B3C7-4A9F-95BB-68854C62902AQ35227751-DEB124C6-3D41-4A3A-A5A6-033292AE2556Q35820624-3D60AC1B-5C34-416A-A713-62575E409552Q35863768-75CA0107-2AAE-4601-B070-38404F4074C8Q35866684-CC561613-ADC4-4AFD-854D-E229FAFD3AA1Q36182287-B125A760-B0D2-468A-85FC-7169DDA7C557Q36188646-E1C07677-1A40-475E-A1C4-5EA4E74510B8Q36300446-EC63DD2D-7BB8-46FF-B78C-1823F6EA7CDEQ36732435-EB7E3FDA-9672-458D-86EE-D92E34DBBC58Q36796847-537DF987-3BB3-4B59-B69B-7EE356CB8A17Q36997861-EAEF7A19-8352-4813-9FE6-B0D0E464AED6Q37078675-9357D9A1-BBB5-4E6E-AFA1-CD10A4C4449FQ37206013-C1D493CA-47D9-4359-B3B7-8FC31EF080FEQ37372273-04100099-EA11-4BAB-9D01-E1D18AD0274AQ37510153-5AF06662-D081-4BA9-A882-D7B3B001EC6CQ37620891-BCF5BD4F-F011-4C56-BD3D-16097B49E24CQ37982353-5916D2E8-1D0F-4F8F-8A52-A1531C0A3378Q38126722-4E98C732-BCCA-4B1D-A975-D06D6CAA259FQ38841110-FDDDB3A7-CC3C-4393-9771-955D643F64A4Q38869420-C864C509-B3EA-49D4-901C-F970ED817EC6Q39250374-8AD46DEC-16E0-45B8-947A-9751E8FDB8D9Q39446317-B784DDF2-929C-4730-A122-3E8FC6E86CBCQ39626735-DB91DDE9-E443-4043-B6D6-A8227FB1C6F9Q42119362-D96233E6-D59A-404C-B906-170C5E35F829Q42501988-35474E0F-8C9D-4B4D-92C1-9240A170FF4AQ42505152-5ACEC229-EDA3-44BC-8E03-AA6F3B002B4AQ42619195-60D2C4B2-64FA-4910-8AE8-AE0EA7C7A10DQ42798174-1EC37A68-656F-427A-BB8D-39349E1E01EEQ49914149-1B002D31-456D-4C62-BE49-EF2BDFA05C2FQ53702017-0357BA66-E994-4432-B98C-49BD51AEDE14Q55130399-0EF1BF83-4E00-496F-92DF-3A8907AA2D45
P2860
Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Two phases of mitogenic signal ...... of inconsistent growth signals
@ast
Two phases of mitogenic signal ...... of inconsistent growth signals
@en
type
label
Two phases of mitogenic signal ...... of inconsistent growth signals
@ast
Two phases of mitogenic signal ...... of inconsistent growth signals
@en
prefLabel
Two phases of mitogenic signal ...... of inconsistent growth signals
@ast
Two phases of mitogenic signal ...... of inconsistent growth signals
@en
P2093
P2860
P50
P1433
P1476
Two phases of mitogenic signal ...... of inconsistent growth signals
@en
P2093
Aldema Sas-Chen
Efrat Lidor-Nili
Eytan Domany
Gideon Rechavi
Gordon B Mills
Jasmine Jacob-Hirsch
Ninette Amariglio
Yaara Zwang
Yosef Yarden
P2860
P304
P356
10.1016/J.MOLCEL.2011.04.017
P577
2011-05-01T00:00:00Z